Using CBD For The Management Of Crohn’s Disease

Extraction Of CBG
Extraction Of CBG
CBD For Crohn’s Disease
CBD For Crohn’s Disease

Crohn’s disease is a form of inflammatory bowel disorder that affects the intestines. It is a disorder in which the gut or digestive tract becomes inflamed. Although Crohn’s disease can affect any section of the gut, the ileum and colon are the most commonly affected regions. Crohn’s disease is characterized by long-term swelling and inflammation of the gastrointestinal tract. As a result, you’ll experience excruciating stomach pains and diarrhea.

Inflammatory bowel disease affects three million people in North America, according to the Centers for Disease Control and Prevention. Crohn’s disease and ulcerative colitis are two of these disorders. Unfortunately, there is no recognized cure for it in Western medicine, though there are various therapies.

Crohn’s Disease Treatments

In modern medicine, there is currently no cure for Crohn’s disease. Surgery and medicine, on the other hand, can provide long-term relief from symptoms. Pharmaceutical treatments for Crohn’s disease, unfortunately, may cause some negative effects. Headaches, vomiting, night sweats, skin problems, infections, and nausea are all possible side effects of those medications.

Many scientists are looking for natural supplements for managing the symptoms of Crohn’s disease. Recent studies have found evidence that CBD may help in managing some of its symptoms.

CBD For Crohn’s Disease

CBD is a cannabinoid compound found in marijuana. Despite the fact that it is derived from the same plant as THC, it has no psychoactive properties, therefore it won’t cause euphoric sensations. In comparison to practically all other drugs, CBD has extremely few adverse effects and poses no danger of dependence. As a result, it’s an excellent choice for people seeking pain management – particularly those who like to avoid opioids and their side effects.

Researchers in Israel tracked and analyzed the effects of cannabis use on individuals with IBD in an observational study. A total of 127 approved medicinal cannabis patients took part in the research. Several evaluative metrics were used to keep track of these subjects. Methods of consumption and monthly consumption rates, the usage of other drugs, side effects, and the long-term implications of medicinal cannabis use were among the topics covered. The authors also determined the exact THC and CBD concentrations taken by these patients.

The researchers employed the Harvey-Bradshaw Index to assess the effects of medicinal cannabis use on health outcomes after 44 months of treatment. The Harvey-Bradshaw Index dropped from 11 to 5 points. A lower score indicates that Crohn’s Disease symptoms are getting better. The patients also reported a significant decline in pain.